O'Shaughnessy Asset Management’s Fulgent Genetics FLGT Stock Holding History

O'Shaughnessy Asset Management’s Portfolio FLGT Stock Details FLGT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-122	Closed	-$11K	–	1662
2021 Q3	$11K	Sell	122 -501	-80%	-$45.5K	﹤0.01%	2129
2021 Q2	$57K	Sell	623 -94	-13%	-$7.5K	﹤0.01%	1530
2021 Q1	$69K	Buy	+717	New	+$74K	﹤0.01%	1315
2020 Q4	–	Sell	-9	Closed	–	–	2121
2020 Q3	$0	Hold	9	–	–	﹤0.01%	1912
2020 Q2	$0	Buy	+9	New	+$138	﹤0.01%	1779

Other funds holding FLGT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Skandinaviska Enskilda Banken (SEB) Stockholm, Sweden $4.34B AUM 19.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

O'Shaughnessy Asset Management's FLGT Position: Q4 2021 in Review

O'Shaughnessy Asset Management sold out of Fulgent Genetics (FLGT) in Q4 2021, closing a stake of 122 shares — an estimated $11K sold.

O'Shaughnessy Asset Management first reported a position in FLGT in Q2 2020 and held it in 5 quarters. The position peaked at $69K in Q1 2021. 299 funds tracked by Wall St. Rank hold FLGT as of Q4 2021.

O'Shaughnessy Asset Management reported no remaining Fulgent Genetics position as of Q4 2021 after selling out during the quarter.
O'Shaughnessy Asset Management sold 122 Fulgent Genetics shares in Q4 2021, an estimated $11K.
O'Shaughnessy Asset Management first reported a position in Fulgent Genetics in Q2 2020 and held it in 5 quarters.
O'Shaughnessy Asset Management's Fulgent Genetics position peaked at $69K in Q1 2021.
299 funds tracked by Wall St. Rank held Fulgent Genetics as of Q4 2021.

Based on O'Shaughnessy Asset Management's 13F filing for Q4 2021, filed 11 Feb 2022.